Common Questions · Prostate surgery · No. 05
Which prostate operation should I have?
There is no best one. There is a best one for a prostate of your size and shape, in a man with your priorities — and the honest trade is that the operations which preserve ejaculation are the ones most likely to need repeating.
By Mr Musaab Yassin, Consultant Urological Surgeon & Andrologist. Oxford and central London.
This is the question I am asked more than any other, and it is the question the internet answers worst. Six or seven branded procedures, each with a website, each quoting its own most flattering trial.
On the NHS you are usually offered what your local unit does. Paying privately buys you the choice — which is worth something only if someone sets out the trade properly.
The trade, in one sentence
The operations that preserve ejaculation remove less tissue and are more likely to need repeating. The operations that last usually mean a dry orgasm.
Almost everything else is detail. A Cochrane network meta-analysis of the minimally invasive treatments found they deliver similar or worse symptom relief and quality of life than TURP, with fewer major adverse events.12 A 2023 European systematic review reached the same conclusion: comparable symptom improvement, but the standard operations remain the reference for durability.3
That is not an argument against the newer options. It is an argument for knowing which side of the trade you are buying.
What actually decides your options
Four things, and only one of them is preference.
Prostate size
Below roughly 30–80mL almost everything is on the table. Above 80mL the field narrows; above 150mL it narrows sharply. Enucleation — HoLEP and its thulium equivalents — is the option whose effectiveness is independent of gland size, which is why it dominates the large-prostate literature.4 Aquablation has now been studied up to 150mL and beyond with sustained results.5
Shape, and the middle lobe in particular
This is the detail that most often invalidates a plan a man has already made. A prostate with a prominent median lobe — a third lobe projecting up into the bladder — is a poor candidate for the prostatic urethral lift, because the implants pull apart lobes that sit either side of the urethra and cannot address one sitting above it.
You cannot know this without imaging or cystoscopy. If someone has recommended a specific branded procedure before looking, they have recommended a procedure, not a plan.
Whether you are in retention
A man managing with a catheter is in a different decision from a man who is merely bothered. Retention shifts the balance towards definitive tissue removal — though not absolutely, and water vapour therapy has been studied specifically in catheter-dependent men with encouraging results.67
What you are actually optimising for
Being dry, or being able to ejaculate, or never doing this again. These pull in different directions and you should say out loud which one matters most, because your surgeon cannot infer it.
The surgeon matters as much as the procedure
This is the part the brochures omit.
Enucleation in particular is technique-dependent. A prospective series from a single very high-volume surgeon found that complications and sequelae still occur after the learning curve is complete — an honest finding from a centre with every reason to publish a flattering one.8 For Aquablation, a 300-case series found composite success rising from 58% in the first fifty cases to 82% after a hundred and fifty.9
So "how many of these do you do a year?" is not a rude question. It is the most useful one you can ask, and it discriminates between providers more sharply than the choice of device does.
What each option is actually for
- TURP — the long-standing reference. Effective, widely available, and the benchmark every trial is measured against. Retrograde ejaculation is likely.
- HoLEP (and thulium enucleation) — removes the most tissue, works at any gland size, and has the lowest retreatment rate of the group. Retrograde ejaculation in most men, and a period of stress leakage in a minority.
- Aquablation — a robotically executed waterjet planned on live ultrasound, with markedly better ejaculatory preservation than TURP. Bleeding is the principal perioperative concern.10
- Rezūm (water vapour) — day-case, ejaculation usually preserved, but symptoms often worsen before they improve and the benefit builds over one to three months.
- UroLift (prostatic urethral lift) — implants that hold the lobes apart. Fast recovery, ejaculation usually preserved, no tissue removed — and the highest retreatment rate of the mainstream options.
- iTIND — a temporary device that reshapes the bladder neck and is then removed. The smallest evidence base of the group.
The question almost nobody asks, and should
If this fails in five years, does it make the next operation harder?
This matters more as the minimally invasive options are used earlier. Implants that sit in the urethra may need to be dealt with at any subsequent operation; tissue that has been scarred by heat is not identical to virgin tissue at enucleation. The honest position is that sequential procedures are common and mostly manageable, but "we can always do something bigger later" is a claim that deserves a specific answer for the specific device being proposed, not a reassuring generality.
Bottom line
Ask for your prostate volume and whether you have a median lobe, before you discuss brands. Say which of dryness, ejaculation and durability you care about most. Ask how many the surgeon does a year, and what plan B looks like.
If a consultation does not produce those four answers, you have not yet had the consultation.
Worth reading alongside: which operations preserve ejaculation, will I need it done again?, and the Evidence Notes on each procedure.
If this sounds like you
A first consultation is £295, and follow-up £190. It usually runs at least twenty minutes; allow up to an hour if you are likely to need a scan, a flow test, or blood or urine tests on the day. You do not need a referral to book privately, and you are under no obligation to proceed with anything.
Send an enquiry · Symptom questionnaire · Compare the treatments, with the evidence
The 10 studies behind this page▾
- Franco JVA, Jung JH, Imamura M, et al. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis. Cochrane Database of Systematic Reviews. 2020. doi:10.1002/14651858.cd013656
- Franco JVA, Tesolin P, Jung JH. Minimally invasive treatments for benign prostatic hyperplasia: a Cochrane network meta-analysis. BJU International. 2021. doi:10.1111/bju.15653
- Cornu JN, Zantek P, Burtt G, et al. Minimally Invasive Treatments for Benign Prostatic Obstruction: A Systematic Review and Network Meta-analysis. European Urology. 2023;83(6):534–547. doi:10.1016/j.eururo.2023.02.028
- Sun F, Yao H, Bao X, et al. The Efficacy and Safety of HoLEP for Benign Prostatic Hyperplasia With Large Volume: A Systematic Review and Meta-Analysis. American Journal of Men's Health. 2022;16(4). doi:10.1177/15579883221113203
- Ritter M, Stein J, Barber N, et al. WATER III: a prospective, partially randomized trial of Aquablation therapy versus transurethral laser enucleation of the prostate. European Urology Focus. 2026. doi:10.1016/j.euf.2026.01.006
- Spinos T, Katafigiotis I, Leotsakos I, et al. Rezûm water vapor therapy for the treatment of patients with urinary retention and permanent catheter dependence secondary to benign prostate hyperplasia: a systematic review of the literature. World Journal of Urology. 2022;41(2):413–420. doi:10.1007/s00345-022-04258-y
- McVary KT, Holland B, Beahrs JR. Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia. Prostate Cancer and Prostatic Diseases. 2019;23(2):303–308. doi:10.1038/s41391-019-0187-5
- Capogrosso P, Ventimiglia E, Fallara G, et al. Holmium laser enucleation of the prostate is associated with complications and sequelae even in the hands of an experienced surgeon following completion of the learning curve. European Urology Focus. 2023. doi:10.1016/j.euf.2023.03.018
- Di Gianfrancesco L, D'Agostino D, Marino F, et al. The core Aquablation pentafecta: a five-domain composite definition of procedural success and learning curve validation in 300 consecutive cases. Journal of Robotic Surgery. 2026. doi:10.1007/s11701-026-03250-7
- Triantafyllou P, Arseniou P, Katsimperis S, et al. Complication profile and safety outcomes of Aquablation in the management of BPH. Medicina. 2025. doi:10.3390/medicina61122076
Mr Musaab Yassin is a Consultant Urological Surgeon and Andrologist practising in Oxford and central London. FRCS (Urol). GMC 6118378. Reviewed September 2026.
This page gives general information and does not replace an individual assessment. Figures quoted come from published research and describe groups of patients rather than any one person — your own history, anatomy and priorities change what they mean for you.